Audentes Therapeutics, Inc., a biotechnology company dedicated to the development and commercialization of innovative treatments for rare diseases using gene therapy technology, has announced the expansion of its leadership team, including the appointment of Suyash Prasad, M.D. as Senior Vice President and Chief Medical Officer. Dr. Prasad is the latest addition to a management group with significant experience and a history of success in the industry. In addition to Dr. Prasad, Audentes recently appointed Michael O’Callaghan, D.V.M., Ph.D. as Senior Vice President, Preclinical Development and Translational Medicine, Barbara Wuebbels, RN as Vice President, Patient Advocacy and Medical Affairs, and Monica Miller as Vice President, Program and Alliance Management.
Help employers find you! Check out all the jobs and post your resume.
